berberine has been researched along with ursodeoxycholic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, R; Di Bisceglie, AM; Lavin, P; Liu, L; Watts, GF; Yu, M | 1 |
| Yoshida, EM | 1 |
| Di Bisceglie, AM; Eksteen, B; Forman, L; Gunn, N; Harrison, SA; Hirschfield, GM; Kowdley, KV; Landis, C; Levy, C; Liberman, A; Sundaram, V | 1 |
| Chu, FH; Dai, ZQ; Gao, F; Gao, S; Jiang, XQ; Kong, JW; Lei, HM; Li, SL; Lu, MJ; Wang, ZJ; Xu, B; Xu, SJ; Zheng, HC | 1 |
3 trial(s) available for berberine and ursodeoxycholic acid
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia.
Topics: Adult; Aged; Berberine; Cholesterol; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Ursodeoxycholic Acid | 2020 |
Berberine Ursodeoxycholate for the Treatment of Primary Sclerosing Cholangitis: The Search for the Elusive Pharmacologic Holy Grail Will Need to Continue.
Topics: Alkaline Phosphatase; Berberine; Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Pilot Projects; Ursodeoxycholic Acid | 2022 |
A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis.
Topics: Alkaline Phosphatase; Berberine; Bile Acids and Salts; Cholangitis, Sclerosing; Humans; Treatment Outcome; Ursodeoxycholic Acid | 2022 |
1 other study(ies) available for berberine and ursodeoxycholic acid
| Article | Year |
|---|---|
[Therapeutic effect of ursodeoxycholic acid-berberine supramolecular nanoparticles on ulcerative colitis based on supramolecular system induced by weak bond].
Topics: Animals; Berberine; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Drugs, Chinese Herbal; Interleukin-6; Mice; Nanoparticles; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2023 |